Sargent Investment Group, LLC Bluebird Bio, Inc. Transaction History

Sargent Investment Group, LLC

  • $616 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$0.85 - $1.26 $420 - $623
-495 Reduced 1.27%
38,515 $37,000
Q1 2024

May 10, 2024
BUY
$0.91 - $1.75 $10,620 - $20,424
11,671 Added 42.69%
39,010 $49,000
Q4 2023

Feb 05, 2024
BUY
$1.32 - $4.83 $3,979 - $14,562
3,015 Added 12.4%
27,339 $37,000
Q2 2023

Jul 31, 2023
BUY
$2.79 - $5.03 $67,863 - $122,349
24,324 New
24,324 $80,000

Others Institutions Holding BLUE

# of Institutions
19
Shares Held
20.3M
Call Options Held
0
Put Options Held
2K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $315M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email